Horace Mann Reports Q4 Revenue of $434.8M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5d ago
0mins
Should l Buy HMN?
Reports Q4 revenue $434.8M, consensus $447M. "In 2025, Horace Mann delivered record core earnings and strong shareholder return on equity," said Horace Mann President and CEO Marita Zuraitis. "While P&C results meaningfully benefitted from lower catastrophe losses, underlying results across all segments are strong and in line with profitability targets. Top-line results increased across all segments, setting the stage for sustained, profitable growth in 2026 and beyond.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HMN
Wall Street analysts forecast HMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HMN is 48.00 USD with a low forecast of 48.00 USD and a high forecast of 48.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
0 Buy
1 Hold
0 Sell
Hold
Current: 44.660
Low
48.00
Averages
48.00
High
48.00
Current: 44.660
Low
48.00
Averages
48.00
High
48.00
About HMN
Horace Mann Educators Corporation is a multiline financial services company focused on helping America’s educators and others who serve the community. The Company's Property & Casualty segment's primary insurance products include private passenger auto insurance, residential home insurance, and personal umbrella insurance. Its Life & Retirement segment markets 403 (b) tax-qualified fixed, fixed indexed and variable annuities; the Horace Mann Retirement Advantage open architecture platform for 403 (b) (7) and other defined contribution plans; traditional term and whole life insurance products and indexed universal life (IUL) products. Its Supplemental & Group Benefits segment offers employer-sponsored products, including accident, critical illness, limited-benefit fixed indemnity insurance, term life, short-term disability and long-term disability, and worksite direct products, including supplemental heart, supplemental cancer, supplemental disability and supplemental accident coverage.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Horace Mann Educators Corporation Reports Record 2025 Earnings
- Record Core Earnings: Horace Mann reported a record core earnings per share of $4.71 for 2025, reflecting a 39% year-over-year increase, which not only showcases strong performance across all segments but also indicates sustained profitability that is likely to attract more investor interest.
- Significant Revenue Growth: Total revenues increased by 7% year-over-year, with net premiums and contract deposits also rising over 7%, demonstrating the company's growing competitiveness in the market and supporting its long-term sustainable development goals.
- Enhanced Brand Awareness: The expansion of marketing and distribution channels led to brand awareness rising from less than 10% to 35%, with website traffic and online quotes more than doubling, which not only strengthens customer acquisition capabilities but also lays a solid foundation for future sales growth.
- Optimistic Future Outlook: Management anticipates core earnings per share for 2026 to be in the range of $4.20 to $4.50, targeting a 10% average compound annual growth rate, reflecting the company's confidence in future growth and commitment to providing sustainable returns to shareholders.
See More
Horace Mann Educators Q4 Earnings Beat Expectations
- Earnings Beat: Horace Mann Educators reported a Q4 non-GAAP EPS of $1.21, exceeding expectations by $0.03, indicating strong profitability amidst competitive pressures.
- Revenue Miss: The company's revenue of $434.8 million, while up 6.3% year-over-year, fell short of the anticipated $447 million, highlighting challenges in market demand and competition.
- Profitability Improvement: Efforts in cost control and operational efficiency have allowed EPS growth to outpace revenue increases, showcasing Horace Mann's commitment to enhancing profitability.
- Positive Market Reaction: Despite the revenue miss, the positive earnings surprise may boost investor confidence and potentially elevate the stock price in the short term, reflecting a favorable outlook for the company.
See More
Horace Mann Educators Set to Release Q4 Earnings on February 3rd
- Earnings Announcement Date: Horace Mann Educators (HMN) is set to announce its Q4 2023 earnings on February 3rd after market close, with consensus EPS estimate at $1.18, reflecting a 29.8% year-over-year decline, while revenue is expected to reach $447 million, indicating a 9.3% year-over-year growth, showcasing resilience in revenue growth.
- Historical Performance Review: Over the past two years, HMN has beaten EPS estimates 100% of the time, although it has only surpassed revenue estimates 25% of the time, indicating stable performance in profitability but a need for improvement in revenue growth.
- Estimates Revision Dynamics: In the last three months, EPS estimates have seen one upward revision and two downward adjustments, while revenue estimates experienced one upward revision with no downward changes, reflecting a cautious market sentiment regarding the company's future performance, which may impact investor confidence.
- Future Outlook: Horace Mann Educators has raised its 2025 core EPS guidance to between $4.50 and $4.70, with all business segments exceeding targets, indicating a positive outlook for the company's profitability and competitive position in the market.
See More
Horace Mann Educators Corp. (HMN) Stock Oversold with RSI at 29.9
- Oversold Signal: Horace Mann Educators Corp. (HMN) has an RSI of 29.9, indicating that after hitting a low of $42.87, the stock may be poised for a rebound, presenting potential buying opportunities for investors.
- Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 59.5, HMN's oversold condition suggests that recent selling pressure may be waning, potentially attracting investors looking for entry points at lower prices.
- Price Fluctuation: HMN's 52-week low is $37.19 and high is $48.325, with the current trading price at $43.05, indicating potential rebound space within its trading range.
- Investor Sentiment: While the stock is currently oversold, investors should carefully assess market sentiment to determine whether to enter at this time, avoiding further downside risks.
See More
KBW Announces Q4 2025 Index Rebalancing with Changes Across Six Indices
- Index Component Changes: The KBW Nasdaq Insurance Index adds four companies, including Arthur J. Gallagher & Co. and Chubb Limited, while dropping four others, reflecting market dynamics.
- Regional Banking Index Update: The KBW Nasdaq Regional Banking Index adds Axos Financial, Inc. and removes Synovus Financial Corp., indicating a focus on emerging fintech companies.
- Dividend Yield Index Adjustments: The KBW Nasdaq Financial Sector Dividend Yield Index adds eight companies and drops eight, demonstrating ongoing investor interest in high-yield investments.
- REIT Index Expansion: The KBW Nasdaq Premium Yield Equity REIT Index adds twelve companies while removing nine, reflecting the vibrancy of the real estate market and investor confidence.
See More
Ex-Dividend Alert: Gilead Sciences, Merck, and Horace Mann Educators
Upcoming Ex-Dividend Dates: Gilead Sciences Inc (GILD), Merck & Co Inc (MRK), and Horace Mann Educators Corp. (HMN) will trade ex-dividend on 12/15/25, with respective dividends of $0.79, $0.85, and $0.35 scheduled for payment on 12/30/25, 1/8/26, and 12/31/25.
Expected Stock Price Adjustments: Following the ex-dividend date, GILD shares are expected to open 0.65% lower, MRK by 0.87%, and HMN by 0.78%, based on their recent stock prices.
Dividend Yield Estimates: The estimated annualized yields for the upcoming dividends are 2.60% for Gilead, 3.48% for Merck, and 3.11% for Horace Mann, reflecting their historical dividend stability.
Current Trading Performance: As of Thursday trading, shares of Gilead Sciences, Merck, and Horace Mann are up approximately 1.7%, 0.8%, and 1.4%, respectively.
See More
Horace Mann Educators Corporation Reports Record 2025 Earnings
- Record Core Earnings: Horace Mann reported a record core earnings per share of $4.71 for 2025, reflecting a 39% year-over-year increase, which not only showcases strong performance across all segments but also indicates sustained profitability that is likely to attract more investor interest.
- Significant Revenue Growth: Total revenues increased by 7% year-over-year, with net premiums and contract deposits also rising over 7%, demonstrating the company's growing competitiveness in the market and supporting its long-term sustainable development goals.
- Enhanced Brand Awareness: The expansion of marketing and distribution channels led to brand awareness rising from less than 10% to 35%, with website traffic and online quotes more than doubling, which not only strengthens customer acquisition capabilities but also lays a solid foundation for future sales growth.
- Optimistic Future Outlook: Management anticipates core earnings per share for 2026 to be in the range of $4.20 to $4.50, targeting a 10% average compound annual growth rate, reflecting the company's confidence in future growth and commitment to providing sustainable returns to shareholders.
See More
Horace Mann Educators Q4 Earnings Beat Expectations
- Earnings Beat: Horace Mann Educators reported a Q4 non-GAAP EPS of $1.21, exceeding expectations by $0.03, indicating strong profitability amidst competitive pressures.
- Revenue Miss: The company's revenue of $434.8 million, while up 6.3% year-over-year, fell short of the anticipated $447 million, highlighting challenges in market demand and competition.
- Profitability Improvement: Efforts in cost control and operational efficiency have allowed EPS growth to outpace revenue increases, showcasing Horace Mann's commitment to enhancing profitability.
- Positive Market Reaction: Despite the revenue miss, the positive earnings surprise may boost investor confidence and potentially elevate the stock price in the short term, reflecting a favorable outlook for the company.
See More
Horace Mann Educators Set to Release Q4 Earnings on February 3rd
- Earnings Announcement Date: Horace Mann Educators (HMN) is set to announce its Q4 2023 earnings on February 3rd after market close, with consensus EPS estimate at $1.18, reflecting a 29.8% year-over-year decline, while revenue is expected to reach $447 million, indicating a 9.3% year-over-year growth, showcasing resilience in revenue growth.
- Historical Performance Review: Over the past two years, HMN has beaten EPS estimates 100% of the time, although it has only surpassed revenue estimates 25% of the time, indicating stable performance in profitability but a need for improvement in revenue growth.
- Estimates Revision Dynamics: In the last three months, EPS estimates have seen one upward revision and two downward adjustments, while revenue estimates experienced one upward revision with no downward changes, reflecting a cautious market sentiment regarding the company's future performance, which may impact investor confidence.
- Future Outlook: Horace Mann Educators has raised its 2025 core EPS guidance to between $4.50 and $4.70, with all business segments exceeding targets, indicating a positive outlook for the company's profitability and competitive position in the market.
See More
Horace Mann Educators Corp. (HMN) Stock Oversold with RSI at 29.9
- Oversold Signal: Horace Mann Educators Corp. (HMN) has an RSI of 29.9, indicating that after hitting a low of $42.87, the stock may be poised for a rebound, presenting potential buying opportunities for investors.
- Market Comparison: Compared to the S&P 500 ETF (SPY) with an RSI of 59.5, HMN's oversold condition suggests that recent selling pressure may be waning, potentially attracting investors looking for entry points at lower prices.
- Price Fluctuation: HMN's 52-week low is $37.19 and high is $48.325, with the current trading price at $43.05, indicating potential rebound space within its trading range.
- Investor Sentiment: While the stock is currently oversold, investors should carefully assess market sentiment to determine whether to enter at this time, avoiding further downside risks.
See More
KBW Announces Q4 2025 Index Rebalancing with Changes Across Six Indices
- Index Component Changes: The KBW Nasdaq Insurance Index adds four companies, including Arthur J. Gallagher & Co. and Chubb Limited, while dropping four others, reflecting market dynamics.
- Regional Banking Index Update: The KBW Nasdaq Regional Banking Index adds Axos Financial, Inc. and removes Synovus Financial Corp., indicating a focus on emerging fintech companies.
- Dividend Yield Index Adjustments: The KBW Nasdaq Financial Sector Dividend Yield Index adds eight companies and drops eight, demonstrating ongoing investor interest in high-yield investments.
- REIT Index Expansion: The KBW Nasdaq Premium Yield Equity REIT Index adds twelve companies while removing nine, reflecting the vibrancy of the real estate market and investor confidence.
See More
Ex-Dividend Alert: Gilead Sciences, Merck, and Horace Mann Educators
Upcoming Ex-Dividend Dates: Gilead Sciences Inc (GILD), Merck & Co Inc (MRK), and Horace Mann Educators Corp. (HMN) will trade ex-dividend on 12/15/25, with respective dividends of $0.79, $0.85, and $0.35 scheduled for payment on 12/30/25, 1/8/26, and 12/31/25.
Expected Stock Price Adjustments: Following the ex-dividend date, GILD shares are expected to open 0.65% lower, MRK by 0.87%, and HMN by 0.78%, based on their recent stock prices.
Dividend Yield Estimates: The estimated annualized yields for the upcoming dividends are 2.60% for Gilead, 3.48% for Merck, and 3.11% for Horace Mann, reflecting their historical dividend stability.
Current Trading Performance: As of Thursday trading, shares of Gilead Sciences, Merck, and Horace Mann are up approximately 1.7%, 0.8%, and 1.4%, respectively.
See More
